[1] Katsuta E, Tanaka S, Mogushi K, et al. Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma.American journal of surgery, 2014,208: 450-456.
[2] 王晓良.PVA颗粒栓塞脾脏红髓小动脉治疗脾亢的临床研究.中国实用医药,2011,06: 45-46.
[3] Nahum S, Joseph G, Gerald B, et al. Society of Interventional Radiology Interventional Oncology Task Force: interventional oncology research vision statement and critical assessment of the state of research affairs.Journal of vascular and interventional radiology : JVIR, 2005,16: 1287-1294.
[4] 曲桂莲,刘卫东,郭建军,等.血管内介入治疗肝癌中C臂CT的应用.介入放射学杂志,2010,19: 563-565.
[5] 杨敏玲,杨志勇,谢春明. 原发性肝癌经导管肝动脉化疗栓塞术后肿瘤残留及新发病灶的CT和数字减影血管造影诊断对比研究.肿瘤研究与临床, 2014,26: 145-147.
[6] 于宝林,卢春凤.肝动脉化疗栓塞术不同栓塞剂对肝功能的影响.中国临床研究,2013,26: 230-231.
[7] 陈俊伟,朱康顺,孟晓春,等.聚乙烯醇颗粒在原发性肝癌经导管肝动脉化疗栓塞术中的应用.中国医学影像技术,2010,26: 559-562.
[8] 陈俊伟,庞鹏飞,孟晓春,等. TACE联合索拉非尼治疗原发性肝癌合并不同分型门静脉癌栓的临床观察.中华医学杂志, 2013,93: 663-667.
[9] 祝朝前,殷军. 腺病毒p53联合经导管肝动脉化疗栓塞术治疗原发性肝癌研究进展.国际外科学杂志, 2015,42: 260-264.
[10] 赵志英,徐晶,杨毕伟,等. 减量化疗肝动脉栓塞治疗肝癌合并腹水的研究. 实用肿瘤杂志, 2014,29: 312-315
[11] 程文元,戴振华,楼丽霞,等. 经皮肝瘤内注射术联合经导管肝动脉化疗栓塞术治疗中晚期肝癌的临床研究.中国基层医药, 2015,11: 2247-2249. |
